AstraZeneca-Merck’s Lynparza wins EU approval for pancreatic cancer The approval was based on results from a late-stage trial in which Lynparza nearly doubled the lifespan of patients AstraZeneca…
CSIR’s anti-cancer drug IIIM-290 enters clinical trial The proposed clinical trial is aimed to assess the safety, tolerability and exposure of the compound in humans along with the…
Proactive Measures to fight pancreatic cancer: Early detection and treatment Dr Amit Singhal, Director and Consultant Gastroenterology, Premier Institute of Gastroenterology, Jalandhar, explains how…